Versión de HTML Básico
44
Manuel Lobo González
Células madre en terapia celular cardíaca
nically relevant populations: lessons from embryonic development. Cell.
2008;132:661-680.
77. Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy
and lessons from the heart. Nature. 2008;453:322-329.
78. Hochedlinger K, Jaenisch R. Nuclear reprogramming and pluri-
potency. Nature. 2006;441:1061-1067.
79. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluri-
potencyand nuclear reprogramming. Cell.2008;132:567-582.
80. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi
T, et al. Generation of induced pluripotent stem cells without Myc from
mouse and human “broblasts. Natur Biotechnol. 2008;26:101-106.
81. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane
JL, Tian S, Nie J, et al. Laflamme. Cardiac Applications for Human Pluripo-
tent Stem Cells. Curr Pharm Des. 2009; 15: 2791–2806.
82. Yamanaka S, Takahashi K. Induction of pluripotent stemcells from
mouse fibroblast cultures.Tanpakushitsu Kakusan Koso. 2006;51:2346-51.
83. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda
K, et al. Induction of pluripotent stem cells from adult humanfibroblasts
by defined factors. Cell. 2007;131:861– 872.
84. Mali P, Chou BK, Yen J, Ye Z, Zou J, Dowey S, et al. Butyrate
greatly enhances derivation of human induced pluripotent stem cells by
promoting epigenetic remodeling and the expression of pluripotency-
associated genes. Stem Cells. 2010;28:713–720
85. Zhu S, Li W, Zhou H, Wei W, Ambasudhan R, Lin T, et al. Repro-
gramming of human primary somatic cells by OCT4 and chemical com-
pounds. Cell Stem Cell. 2010;7:651–655
86. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bru-
neau BG, et al. Direct reprogramming of fibroblasts into functional car-
diomyocytes by defined factors. Cell 2010; 142: 375 – 386.
87. Pera MF. Stem cells: the dark side of induced pluripotency. Na-
ture. 2011;471:46–7.
88. Chamuleau SA, Vrijsen KR, Rokosh DG, Tang XL, Piek JJ, Bolli R.
Cell therapy for ischaemic heart disease: Focus on the role of resident
cardiac stem cells. Neth Heart J 2009; 17: 199 – 207.
89. Mozid AM, Arnous S, Sammut EC, Mathur A. Stem cell therapy
for heart diseases. Br Med Bull 2011; 98: 143 – 159.